Design and Evaluation of 3-Phenyloxetane Derivative Agonists of the Glucagon-Like Peptide-1 Receptor.
3-Phenyloxetane 衍生物作為胰高血糖素樣肽-1 受體的激動劑的設計與評估。
J Med Chem 2024-08-14
Effects of Early Life Exposures to the Aryl Hydrocarbon Receptor Ligand TCDF on Gut Microbiota and Host Metabolic Homeostasis in C57BL/6J Mice.
早期接觸芳香烴受體配體 TCDF 對 C57BL/6J 小鼠腸道微生物群及宿主代謝穩態的影響。
Environ Health Perspect 2024-08-14
The Effect of Glucagon-Like Peptide-1 Receptor Agonists on Diabetic Retinopathy at a Tertiary Care Center.
在三級醫療中心中,Glucagon-Like Peptide-1 受體激動劑對糖尿病視網膜病變的影響。
Ophthalmol Sci 2024-08-14
Distinct Profiles and New Pharmacological Targets for Heart Failure with Preserved Ejection Fraction.
心臟衰竭伴保留射血分數的不同特徵及新藥理靶點。
Rev Cardiovasc Med 2024-08-14
Incretin-based therapies for the management of cardiometabolic disease in the clinic: Past, present, and future.
臨床上基於胰高血糖素樣肽的療法在心代謝疾病管理中的應用:過去、現在與未來。
Med Res Rev 2024-08-14